Genetic analyses identify rare variants in complement regulators (CFH, CFI, MCP) and proteins (C5, C6), suggesting a shared mechanism between preeclampsia and complement-mediated disorders like atypical hemolytic uremic syndrome (aHUS). This evidence concerns the gene CFH and preeclampsia.